Not for human use, for research purposes only
July 6, 2026 2 min read Research Guides Updated September 13, 2026

Retatrutide: Receptor Activity and Research Material Specifications

Retatrutide (LY3437943): triple-receptor activity (GLP-1, GIP and glucagon receptors), and what to verify in research material.

By Milo-Lab Research Team

Retatrutide (development code LY3437943) is available to researchers in Thailand, including Bangkok, through specialist peptide suppliers as a lyophilised research vial. It is an investigational compound.

Searches such as “retatrutide Thailand” are mostly about sourcing. This guide covers the compound’s receptor activity and what to verify in research material before ordering.

What Is Retatrutide?

Retatrutide is Eli Lilly’s investigational triple-receptor peptide, activating GLP-1, GIP and glucagon receptors simultaneously. All three are G-protein-coupled receptors that signal through cAMP. The glucagon receptor, expressed in hepatocytes, is what differentiates retatrutide from single- or dual-receptor agonists such as semaglutide and tirzepatide.

Sourcing Retatrutide in Thailand

Researchers obtain retatrutide through peptide suppliers positioned explicitly as research-chemical vendors. When evaluating a source, the same due-diligence checklist applies as for any research peptide:

  • A batch-specific certificate of analysis confirming identity and purity
  • Explicit research-use-only labelling, not marketing language implying a therapeutic outcome
  • Traceable lot numbers matching the COA on file
  • Clear cold-chain or storage guidance from dispatch to delivery, since retatrutide ships as a lyophilised powder

Retatrutide vs. Other Incretin Peptides

Retatrutide’s triple-receptor design places it one receptor beyond tirzepatide (dual GLP-1/GIP agonist) and semaglutide (GLP-1-only agonist). No head-to-head study of retatrutide and tirzepatide has been published. For a receptor-level side-by-side, see the GLP-1 comparison.

Research Use Only

Retatrutide is an investigational research compound for laboratory use by qualified researchers. Milo-Lab gives no use or dosing advice, and nothing in this article is medical advice.

For research purposes only. Not for human consumption.

Retatrutide Thailand GLP-1 metabolic research triple agonist

Interested in the peptides discussed in this article?

Browse our full catalog of research-grade peptides or contact us with questions about product specifications.